1-6 of 6
J. F. San Miguel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiparameter Flow Cytometry Remission Is the Most Relevant Prognostic Factor for Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation

Bruno Paiva, Maria-Belén Vidriales, Jorge Cerveró, Gema Mateo, Jose J. Pérez, Maria Angeles Montalbán, Anna Sureda, Laura Montejano, Norma C. Gutiérrez, Alfonso García de Coca, Natalia de las Heras, MD, Maria Victoria Mateos, Maria-Consuelo López-Berges, Raimundo García-Boyero, Josefina Galende, José Hernández, Luis Palomera, Dolores Carrera, Rafael Martínez, Javier de la Rubia, Alejandro Martín, Joan Blade, Juan José Lahuerta, Alberto Orfao, J. F. San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 737.
https://doi.org/10.1182/blood.V112.11.737.737
Published: 2008
Journal Articles

Panobinostat (LBH589) a Promising New Partner for Combination with Doxorubicin in Acute Myeloid Leukemia.

Patricia Maiso, Enrique Colado, Enrique M Ocio, Mercedes Garayoa, Peter Atadja, Atanasio Pandiella, J. F. San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1638.
https://doi.org/10.1182/blood.V112.11.1638.1638
Published: 2008
Journal Articles

Alternating Bortezomib and Dexamethasone as Induction Regimen Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Younger Patients with Multiple Myeloma: Results of a PETHEMA Phase II Trial.

Laura Rosinol, MD, Albert Oriol, MD, M. -Victoria Mateos, MD, Anna Sureda, MD, Joaquin Diaz-Mediavilla, MD, Adrian Alegre, MD, Juan-Jose Lahuerta, MD, Javier De La Rubia, MD, Carlos Herrero, MD, Helgi Van de Velde, MD, J. F. San Miguel, MD, Joan Blade, MD
Journal: Blood
Blood (2006) 108 (11): 3086.
https://doi.org/10.1182/blood.V108.11.3086.3086
Published: 2006
Journal Articles

Long Remission Are Possible after Non Myeloablative Transplant in Patients with Follicular Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

María-Dolores Caballero, MD, PhD, Rodrigo Martino, MD, María-Victoria Mateos, MD, Phd, Javier Briones, MD, Javier de la Serna, MD, Jose-Francisco Tomás, MD, Reyes Arranz, MD, Jose-Luis Díez, MD, Vicente Rubio, MD, Josep-María Ribera, MD, José-María Moraleda, MD, PhD, Guillermo Sanz, MD, Alvaro Urbano, MD, PhD, José Sarrá, MD, Antonia Sampol, MD, Jordi Sierra, MD, PhD, J. F. San Miguel, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3024.
https://doi.org/10.1182/blood.V108.11.3024.3024
Published: 2006
Journal Articles

High-Dose Therapy/Stem Cell Support (HDT), Including Tandem Transplant, for Primary Refractory Multiple Myeloma (MM): Results from the Spanish Myeloma Group (PETHEMA/GEM) in 49 Patients.

L. Rosinol, R. Garcia-Sanz, J. J. Lahuerta, M. Hernandez-Garcia, A. Sureda, J. de la Rubia, J. M. Ribera, B. Hernandez-Ruiz, D. Carreras, I. Navarro, J. C. Garcia-Ruiz, S. Gardella, J. Garcia-Larana, J. Diaz-Mediavilla, J. F. San Miguel, J. Blade
Journal: Blood
Blood (2005) 106 (11): 5472.
https://doi.org/10.1182/blood.V106.11.5472.5472
Published: 2005
Journal Articles

Preliminary Report from an Exploratory Phase II Trial with Plitidepsin (Aplidin®) in Patients with Refractory/Relapsed Multiple Myeloma.

M. V. Mateos, MD, J. Blade, MD, F. Prosper, MD, J. J. Lahuerta, MD, R. Garcia-Sanz, MD, M. Cibeira, MD, L. Rusiñol, MD, F. Escalante, MD, M. Ruiz, MD, P. G. Richardson, MD, J. F. San Miguel, MD
Journal: Blood
Blood (2005) 106 (11): 2569.
https://doi.org/10.1182/blood.V106.11.2569.2569
Published: 2005